Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_349943306

Sophiris halts cancer study after patient death

June 25, 2018
Research and Development, Sales and Marketing Cancer, Sophiris, pharma, prostate cancer

Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …

News
lilly_entrance_web

Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2

June 25, 2018
Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma

Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …

News
sandi_peterson

J&J’s second-in-command to retire, alongside executive restructure

June 25, 2018
Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …

News
roche__tree

Roche’s Tecentriq combo extends life in untreated lung cancer

June 25, 2018
Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq

Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …

News

NICE backs Sanofi’s new treatment for atopic dermatitis

June 22, 2018
Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …

News
fda2outsideweb

FDA approves first continuous glucose monitoring system

June 22, 2018
Medical Communications, Sales and Marketing FDA, diabetes, pharma

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …

News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018
Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …

News
roche__tree

Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS

June 22, 2018
Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …

News
shutterstock_141299494

Elderly cancer cases to increase 80% by 2035, says CRUK

June 21, 2018
Medical Communications, Research and Development CRUK, Cancer, Cancer Research UK, NHS, UK, pharma

A new report from Cancer Research UK has indicated that the number of UK  citizens over the age of 75 …

News
920x920

Purdue culls 350 positions, eradicates sales force

June 21, 2018
Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma

Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …

News
shutterstock_38078521

Anika’s osteoarthritis pain drug falls short at Phase 3

June 21, 2018
Research and Development Anika Therapeutics, Cingal, osteoarthritis, pharma

Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …

News

Novo’s oral semaglutide beats Victoza and Januvia in diabetes

June 21, 2018
Research and Development Januvia, MSD, Novo Nordisk, Victoza, pharma, semaglutide

Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …

News
shutterstock_138095450

Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies

June 21, 2018
Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …

News
nhs_sign

NHS could save £7 billion via new diagnostic techniques

June 20, 2018
Medical Communications, Research and Development NHS, pharma

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save …

News
shutterstock_159488225

Sarepta shares surge after gene therapy leads to microdystrophin expression in DMD patients

June 20, 2018
Research and Development Duchenne Muscular Dystrophy, pharma, sarepta

This week, shares in Sarepta Therapeutics rocketed by 80% after the company released preliminary data from a Phase 1/2a trial …

News
novo_nordisk_flag

Kallyope and Novo Nordisk announce obesity and diabetes collaboration

June 20, 2018
Research and Development Kallyope, Novo Nordisk, diabetes, obesity, pharma

Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the …

News
shutterstock

“Extremely promising” blood test for autism impresses with 88% accuracy

June 20, 2018
Research and Development autism, pharma

A blood test designed to support the clinical determination of whether a child is on the autistic spectrum has been …

News
Pharma on Facebook

Facebook unveils new feature to battle opioid crisis

June 20, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …

News

FDA places hold on Ziopharm CAR-T trial

June 19, 2018
Manufacturing and Production, Research and Development CAR-T, FDA, pharma, ziopharm

CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026